BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9871540)

  • 1. Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors.
    Duncia JV; Santella JB; Higley CA; VanAtten MK; Weber PC; Alexander RS; Kettner CA; Pruitt JR; Liauw AY; Quan ML; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):775-80. PubMed ID: 9871540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.
    Sasmal PK; Reddy DS; Talwar R; Venkatesham B; Balasubrahmanyam D; Kannan M; Srinivas P; Kyasa SK; Devi BN; Jadhav VP; Khan SK; Mohan P; Chaudhury H; Bhuniya D; Iqbal J; Chakrabarti R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):562-8. PubMed ID: 21075633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitors.
    Young MB; Barrow JC; Glass KL; Lundell GF; Newton CL; Pellicore JM; Rittle KE; Selnick HG; Stauffer KJ; Vacca JP; Williams PD; Bohn D; Clayton FC; Cook JJ; Krueger JA; Kuo LC; Lewis SD; Lucas BJ; McMasters DR; Miller-Stein C; Pietrak BL; Wallace AA; White RB; Wong B; Yan Y; Nantermet PG
    J Med Chem; 2004 Jun; 47(12):2995-3008. PubMed ID: 15163182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.
    Sakya SM; Shavnya A; Cheng H; Li C; Rast B; Li J; Koss DA; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML; Lynch MP
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1042-5. PubMed ID: 18182290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.
    von Matt A; Ehrhardt C; Burkhard P; Metternich R; Walkinshaw M; Tapparelli C
    Bioorg Med Chem; 2000 Sep; 8(9):2291-303. PubMed ID: 11026541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.
    Al-Hourani BJ; Sharma SK; Suresh M; Wuest F
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2235-8. PubMed ID: 22341941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
    Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cu(OH)(TMEDA)]₂Cl₂-catalyzed regioselective 2-arylation of 5-substituted tetrazoles with boronic acids under mild conditions.
    Onaka T; Umemoto H; Miki Y; Nakamura A; Maegawa T
    J Org Chem; 2014 Jul; 79(14):6703-7. PubMed ID: 24962401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studies.
    Hu Z; Wang C; Glunz PW; Li J; Cheadle NL; Chen AY; Chen XQ; Myers JE; Guarino VR; Rose A; Sack JS; Sitkoff D; Taylor DS; Xu S; Yan C; Zhang H; Zhang L; Hennan J; Adam LP; Wexler RR; Quan ML
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127495. PubMed ID: 32798651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
    Howard N; Abell C; Blakemore W; Chessari G; Congreve M; Howard S; Jhoti H; Murray CW; Seavers LC; van Montfort RL
    J Med Chem; 2006 Feb; 49(4):1346-55. PubMed ID: 16480269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiviral evaluation of novel 5-(N-Aryl-aminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazoles and pyrazolyl derivatives.
    Abdel-Aal MT; El-Sayed WA; El-Kosy SM; El-Ashry el SH
    Arch Pharm (Weinheim); 2008 May; 341(5):307-13. PubMed ID: 18404774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
    Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of benzo[1,2-d;3,4-d']diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists.
    Piersanti G; Giorgi L; Bartoccini F; Tarzia G; Minetti P; Gallo G; Giorgi F; Castorina M; Ghirardi O; Carminati P
    Org Biomol Chem; 2007 Aug; 5(16):2567-71. PubMed ID: 18019530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Substituted pyrazoles and 4-substituted triazoles as inhibitors of human 15-lipoxygenase-1.
    Pelcman B; Sanin A; Nilsson P; No K; Schaal W; Öhrman S; Krog-Jensen C; Forsell P; Hallberg A; Larhed M; Boesen T; Kromann H; Vogensen SB; Groth T; Claesson HE
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3024-9. PubMed ID: 26037322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: Synthesis and biological evaluation.
    Mesenzani O; Massarotti A; Giustiniano M; Pirali T; Bevilacqua V; Caldarelli A; Canonico P; Sorba G; Novellino E; Genazzani AA; Tron GC
    Bioorg Med Chem Lett; 2011 Jan; 21(2):764-8. PubMed ID: 21167709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship of novel and effective apixaban derivatives as FXa inhibitors containing 1,2,4-triazole/pyrrole derivatives as P2 binding element.
    Wang Y; Sun X; Yang D; Guo Z; Fan X; Nie M; Zhang F; Liu Y; Li Y; Wang Y; Gong P; Liu Y
    Bioorg Med Chem; 2016 Nov; 24(21):5646-5661. PubMed ID: 27663548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annular Tautomerism of 3(5)-Disubstituted-1
    Kusakiewicz-Dawid A; Porada M; Dziuk B; Siodłak D
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31330976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents.
    Maxwell JR; Wasdahl DA; Wolfson AC; Stenberg VI
    J Med Chem; 1984 Dec; 27(12):1565-70. PubMed ID: 6094808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.